Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: wyllisx2 who wrote (39592)	3/11/2009 7:47:28 PM
From: Rangle	Respond to of 48461

Check this article out,...an interesting read on what happend,.... villagevoice.com Glad winter is almost gone My viking blood is tired of it....heh .

To: wyllisx2 who wrote (39592)	3/11/2009 10:18:33 PM
From: Baton	Read Replies (2) \| Respond to of 48461

The RFP for smallpox is 90 pages long and offers more than a simple drug purchase. Those in the know are certain that this could only be met by SIGA. If that is the case, the initial doses will bring 400-500M. With 36M shares outstanding that equals earnings of over $2.60 PS. With the company potential, allowing a 30PE is not far fetched. Remember this is the first contract from one country with one of their many drugs in development. I would expect some offers from larger companies.